Home
About Us
Team
Services
News
Partners
Advisory Board
Contact
54975
News
CUTISS launches Series C financing round to advance the development of its personalized skin technology, paving the way towards commercialization
THE COMMUNICATIONS STRATEGY GROUP INC., A LIFE SCIENCES CONSULTANCY, ANNOUNCES TWO NEW ADVISORY BOARD MEMBERS REFLECTIVE OF FIRM’S GROWING GLOBAL PRACTICE
Aardvark Therapeutics Announces Receipt of FDA Rare Pediatric Disease Designation for Prader-Willi Syndrome and Expands the Ongoing Phase 2 Clinical Trial
Aardvark Therapeutics Announces FDA Orphan Drug Designation Granted to ARD-101, a Novel Drug Candidate for Prader-Willi Syndrome
We need more than brain injury awareness: We need new treatment
Back To Top